Reading Time: 2 minutes

Sphere Fluidics appoints Edward Rayner as Non-Executive Director

Sphere Fluidics has recently announced the appointment of Edward Rayner as their new Non-Executive Director. With a wealth of experience in the biotech and life sciences industries, Rayner is expected to bring valuable insights and expertise to the company as they continue to grow and expand their operations.

Sphere Fluidics is a leading company in the field of single-cell analysis and characterization, offering innovative solutions for drug discovery, diagnostics, and bioprocessing. With a focus on improving the efficiency and accuracy of cell analysis, Sphere Fluidics has developed a unique technology platform that allows for the rapid screening and isolation of individual cells based on their characteristics.

Edward Rayner brings over 25 years of experience in the biotech and life sciences industries to his new role as Non-Executive Director at Sphere Fluidics. With a background in business development, corporate strategy, and commercialization, Rayner has a proven track record of driving growth and success in the companies he has worked with.

Rayner’s appointment comes at a crucial time for Sphere Fluidics, as they look to expand their presence in the global market and further develop their technology platform. With his expertise in strategic planning and business development, Rayner is expected to play a key role in helping Sphere Fluidics achieve their long-term goals and objectives.

In a statement announcing the appointment, Frank Craig, CEO of Sphere Fluidics, expressed his excitement about having Rayner join the company’s board of directors. “We are thrilled to welcome Edward Rayner to the Sphere Fluidics team,” said Craig. “His extensive experience in the biotech and life sciences industries will be invaluable as we continue to grow and expand our operations. We look forward to working with him to drive the success of Sphere Fluidics in the years to come.”

Rayner himself expressed his enthusiasm about joining Sphere Fluidics, citing the company’s innovative technology and strong leadership team as key factors in his decision to come on board. “I am excited to be joining Sphere Fluidics at this exciting time in their growth journey,” said Rayner. “The company’s unique technology platform has the potential to revolutionize the field of single-cell analysis, and I look forward to working with the team to help realize this potential.”

As Non-Executive Director, Rayner will work closely with the executive team at Sphere Fluidics to provide strategic guidance and support on key business decisions. His extensive network of contacts in the biotech and life sciences industries will also be instrumental in helping Sphere Fluidics forge new partnerships and collaborations to drive growth and innovation.

In addition to his role at Sphere Fluidics, Rayner currently serves as a Non-Executive Director on the boards of several other companies in the biotech and life sciences sectors. His diverse background and experience make him a valuable addition to any company looking to accelerate their growth and achieve success in a competitive market.

Overall, Edward Rayner’s appointment as Non-Executive Director at Sphere Fluidics is a positive development for the company and a testament to their commitment to attracting top talent to support their growth and expansion efforts. With Rayner on board, Sphere Fluidics is well-positioned to achieve their strategic objectives and continue to lead the way in the field of single-cell analysis and characterization.

Source link

Cell, Healthcare, Microfluidics, Research, Technology

#Sphere #Fluidics #appoints #Edward #Rayner #NonExecutive #Director